PureTech Health plc PRTC NASDAQ

PureTech Health plc (PRTC) generated $-45.94M in operating cash flow for quarter ending 2025-06-30. After capital expenditures of $0.00, free cash flow was $-45.94M.

Free cash flow margin was -2482% of revenue. Cash conversion ratio was 1.03x, indicating earnings are backed by cash.

The company returned $2.05M in share buybacks to shareholders during the quarter.

Criteria supported by this page:

• HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (50/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (100/100) — Cash conversion ratio was 1.03x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 72/100 with 4/7 criteria passed.